Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
J Gastrointest Surg ; 10(5): 734-9, 2006 May.
Article in English | MEDLINE | ID: mdl-16713547

ABSTRACT

Recurrence of hepatic hydatid disease is still a serious problem in endemic areas like our country. In this study, we present the causes and management of recurrences after surgical therapy of the hepatic hydatid cysts. Hepatic hydatid cyst patients treated surgically and followed afterward at Istanbul University, Cerrahpasa Medical Faculty, Department of General Surgery between January 1998 and January 2003 were evaluated retrospectively. During this period, 172 primary patients with hepatic hydatid disease were attended to at our clinic. Morbidity and mortality rates for this series were 5.8% and 0.58%, respectively. Recurrence rate was 4.65% during the follow-up period of 60.5 months (range, 25-84 months). Primary causes of recurrence were thought to be unnoticed cysts with exophytic development due to inadequate incision and exposition and spreading of the disease during conservative operative interventions. It is concluded that selection of the proper incision allowing complete exposition, and performance of pericystectomy in solitary, peripherally located cysts prevent recurrence.


Subject(s)
Echinococcosis, Hepatic/surgery , Adolescent , Adult , Aged , Albendazole/therapeutic use , Echinococcosis, Hepatic/drug therapy , Echinococcosis, Hepatic/epidemiology , Echinococcosis, Hepatic/prevention & control , Endemic Diseases , Female , Humans , Male , Middle Aged , Retrospective Studies , Secondary Prevention , Turkey/epidemiology
2.
Pancreatology ; 3(4): 352-6, 2003.
Article in English | MEDLINE | ID: mdl-12891000

ABSTRACT

Primitive neuroectodermal tumor (PNET) of the pancreas is extremely rare. Although the diagnosis of PNET is suggested by the light microscopic appearance of the tumor, it should be confirmed by the immunohistochemical evaluation of the c-myc expression and if possible, further determination of the particular chromosome translocation, t(11;22)(q24,q12). In this report, we present a male patient with pancreatic PPNET who had been followed up for 50 months. The related literature is also reviewed. In our case, the pathologic diagnosis was based on the positive immunoreactivity for CD99 in many of the tumor cells. The complementary cytogenetic studies were not possible in the private setting of the patient's treatment. The patient was 31 years old when first operated. Within 4 months of the first operation he had local recurrence. In the third year of his follow-up he had been discovered to have pulmonary metastases and another metastatic tumor in his lung was diagnosed the year after. The metastatic foci were primarily treated by surgical resections. He had chemotherapy after each resection of pulmonary metastatic foci. After 50 months of the initial surgical intervention, he succumbed to widespread thoracic and bone metastases. Because of the extreme rarity of PPNET in the pancreas, and its rather protracted course, we think our case may further contribute to the ever expanding database for this particular entity.


Subject(s)
Neuroectodermal Tumors, Primitive/pathology , Pancreatic Neoplasms/pathology , 12E7 Antigen , Adult , Antigens, CD/metabolism , Cell Adhesion Molecules/metabolism , Combined Modality Therapy , Humans , Immunohistochemistry , Laparotomy , Lung Neoplasms/secondary , Male , Neuroectodermal Tumors, Primitive/diagnostic imaging , Neuroectodermal Tumors, Primitive/therapy , Pancreatic Neoplasms/diagnostic imaging , Pancreatic Neoplasms/therapy , Paraffin Embedding , Synaptophysin/metabolism , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...